[go: up one dir, main page]

AR051974A1 - Procedimiento para la preparacion de un antagonista del leucotrieno y variedad cristalina del mismo - Google Patents

Procedimiento para la preparacion de un antagonista del leucotrieno y variedad cristalina del mismo

Info

Publication number
AR051974A1
AR051974A1 ARP050104981A ARP050104981A AR051974A1 AR 051974 A1 AR051974 A1 AR 051974A1 AR P050104981 A ARP050104981 A AR P050104981A AR P050104981 A ARP050104981 A AR P050104981A AR 051974 A1 AR051974 A1 AR 051974A1
Authority
AR
Argentina
Prior art keywords
compound
preparation
formula
leucotrene
antigonist
Prior art date
Application number
ARP050104981A
Other languages
English (en)
Inventor
Gutierrez Iolanda Chamorro
I Llado Jordi Bosch
I Grau Elies Molins
Original Assignee
Medichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medichem Sa filed Critical Medichem Sa
Publication of AR051974A1 publication Critical patent/AR051974A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente se refiere al ácido libre de este compuesto en forma cristalina, que se obtiene, por primera vez, a través del procedimiento. Reivindicacion 1: Un procedimiento para la preparacion de un compuesto de formula (1), en la cual R representa H o Na, y dicho procedimiento consiste en: a) hacer reaccionar un compuesto de formula (2), con el ácido 1-(mercaptometil)-ciclopropanoacético de formula (3), en presencia de una base, b) acidificar la solucion obtenida para producir un compuesto de formula (4), c) y opcionalmente, transformar el compuesto obtenido en la etapa b) en un compuesto de formula (5).
ARP050104981A 2004-11-30 2005-11-29 Procedimiento para la preparacion de un antagonista del leucotrieno y variedad cristalina del mismo AR051974A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2004/013598 WO2006058545A1 (en) 2004-11-30 2004-11-30 New process for the preparation of a leukotriene antagonist

Publications (1)

Publication Number Publication Date
AR051974A1 true AR051974A1 (es) 2007-02-21

Family

ID=34959312

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104981A AR051974A1 (es) 2004-11-30 2005-11-29 Procedimiento para la preparacion de un antagonista del leucotrieno y variedad cristalina del mismo

Country Status (6)

Country Link
US (1) US20080214822A1 (es)
EP (1) EP1817289A1 (es)
AR (1) AR051974A1 (es)
CA (1) CA2589936A1 (es)
IL (1) IL183255A0 (es)
WO (1) WO2006058545A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005015174D1 (de) 2004-04-21 2009-08-13 Teva Pharma Verfahren zur herstellung von montelukast-natrium
KR20090015186A (ko) 2005-07-05 2009-02-11 테바 파마슈티컬 인더스트리즈 리미티드 몬테루카스트의 정제
WO2007069261A1 (en) 2005-12-13 2007-06-21 Msn Laboratories Limited An improved process for the preparation of montelukast and its pharmaceutically acceptable salts
IL181607A0 (en) * 2006-02-27 2007-07-04 Chemagis Ltd Novel process for preparing montelukast and salts thereof
US20090281323A1 (en) * 2006-04-12 2009-11-12 Glade Organics Private Limited Process for the manufacture of montelukast sodium
US20060223999A1 (en) * 2006-05-10 2006-10-05 Chemagis Ltd. Process for preparing montelukast and precursors thereof
US20090326232A1 (en) * 2006-06-26 2009-12-31 Uttam Kumar Ray Process for the Preparation of Leukotriene Receptor Antagonist (Montelukast Sodium)
WO2008015703A2 (en) * 2006-08-04 2008-02-07 Matrix Laboratories Ltd Process for the preparation of montelukast and its salts thereof
EP1886997A1 (en) * 2006-08-09 2008-02-13 Esteve Quimica, S.A. Process for the purification of montelukast
US8115004B2 (en) 2006-11-20 2012-02-14 Msn Laboratories Limited Process for pure montelukast sodium through pure intermediates as well as amine salts
KR100774088B1 (ko) 2006-12-14 2007-11-06 한미약품 주식회사 몬테루카스트의 제조방법 및 이에 사용되는 중간체
WO2008087628A1 (en) * 2007-01-15 2008-07-24 Chemagis Ltd. Process for preparing montelukast sodium containing controlled levels of impurities
WO2009042984A1 (en) 2007-09-28 2009-04-02 Codexis, Inc. Ketoreductase polypeptides and uses thereof
KR100893756B1 (ko) * 2009-01-14 2009-04-22 주식회사 메디켐코리아 몬테루카스트의 효율적 제조방법
WO2010148209A2 (en) * 2009-06-19 2010-12-23 Dr. Reddy's Laboratories Ltd. Preparation of montelukast
WO2011121091A1 (en) 2010-03-31 2011-10-06 Krka, D.D., Novo Mesto Efficient synthesis for the preparation of montelukast and novel crystalline form of intermediates therein
HUP1000425A2 (en) 2010-08-11 2012-03-28 Richter Gedeon Nyrt Process for the production of montelukast sodium
AU2012320010B2 (en) * 2011-07-26 2017-03-30 Sun Pharma Advanced Research Company Ltd. Quinoline-, quinoxaline or benzothiazole based cysteinyl leukotriene antagonists (LTD4)
US9487487B2 (en) 2012-05-18 2016-11-08 Laurus Labs Private Limited Process for preparation of montelukast sodium
CN105085391B (zh) * 2015-06-10 2017-08-22 广东默泰同创医药科技有限公司 用作白三烯受体拮抗剂的环丙基不饱和喹啉化合物及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053209C (en) * 1990-10-12 1998-12-08 Michel L. Belley Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
US5565473A (en) * 1990-10-12 1996-10-15 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
TW416948B (en) * 1993-12-28 2001-01-01 Merck & Co Inc Process for the preparation of leukotriene antagonists
AU2003209043A1 (en) * 2002-02-07 2003-09-02 Dr. Reddy's Laboratories Ltd. Novel anhydrous amorphous forms of montelukast sodium salt
PT1631550E (pt) * 2003-06-06 2012-04-19 Morepen Lab Ltd Um método melhorado para a preparação do ácido montelucaste e do seu sal de sódio na forma amorfa
PT1678139E (pt) * 2003-10-10 2011-11-28 Synhton B V Montelucaste em estado sólido

Also Published As

Publication number Publication date
WO2006058545A1 (en) 2006-06-08
US20080214822A1 (en) 2008-09-04
CA2589936A1 (en) 2006-06-08
IL183255A0 (en) 2007-09-20
EP1817289A1 (en) 2007-08-15

Similar Documents

Publication Publication Date Title
AR051974A1 (es) Procedimiento para la preparacion de un antagonista del leucotrieno y variedad cristalina del mismo
AR066130A1 (es) Formas cristalinas de saxagliptina y procesos para preparar las mismas
CY1110800T1 (el) Μεθανοσουλφονικα αλατα αβιρατερονης-3-εστερων και ανακτηση αλατων αβιρατερονης-3-εστερων απο διαλυμα σε μεθυλο τριτ-βουτυλαιθερα
CO6140036A2 (es) Metodo para producir prasugrel de alta pureza o una sal acida de adicion del mismo
NI200500031A (es) Nuevos procesos para la sintesis de ivabradine y ademas sales que la contienen con un acido aceptable farmaceuticamente.
EA200702670A1 (ru) Препарат тиенопиридинового ингибитора агрегации тромбоцитов
CR8640A (es) Proceso para producir un compuesto de 5-hidroxi-4-tiometilpirazol
NO20074642L (no) Fremgangsmate for a lage trans-1-((1R,3S)-6-klor-3-fenylindan-1-yl)-3,3-dimetylpiperazin
AR050518A1 (es) Proceso de amonolisis para la preparacion de intermedarios para inhibidores de dpp iv
CY1112520T1 (el) Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες
UY37421A (es) Método para producir la forma cristalina de modificación a de calcobutrol
AR064658A1 (es) Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma
AR044019A1 (es) Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas
AR116423A1 (es) Un proceso de fabricación de compuestos heterocíclicos de 2-nitroimino
ES2496447T3 (es) Procedimiento de preparación de un aminoácido a partir de 2-aminobutirolactona
ATE519737T1 (de) Organische verbindungen
NO20075930L (no) Fremgangsmate for fremstilling av alkalimetallsalt
UY31681A1 (es) Procedimiento de preparcion de combretastatina
CY1112714T1 (el) Διαδικασια για την παρασκευη υψηλης-καθαροτητας μελοξικαμης και αλατος καλιου της μελοξικαμης
AR057909A1 (es) Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.
EA200801960A1 (ru) Соли дулоксетина
PE20060466A1 (es) Proceso para preparar bisulfato de atazanavir y formas cristalinas del mismo
RU2008105019A (ru) N-замещенные 4-метил-2,6-дихлорникотиноил-мочевины в качестве антидотов 2,4-д на подсолнечнике
AR049695A1 (es) Procedimiento para preparar un compuesto tiazol y compuesto intermediario de sintesis
AR066430A1 (es) Proceso para preparar inhibidores de aromatasa y forma cristalina de exemestano

Legal Events

Date Code Title Description
FB Suspension of granting procedure